Sun Pharmaceutical Industries Share Price Analysis April 2026
Sun Pharmaceutical Industries — Equity Research Report Zumedha Equity Research ◆ India Pharmaceuticals ◆ NSE: SUNPHARMA | BSE: 524715 31 Mar 2026 CMP ₹1,769 (as on 31 Mar 2026) 52W H/L ₹1,851 / ₹1,548 Mkt Cap ₹4,31,000 Cr P/E 38.3× Rating ★…
Tata Consultancy Services Share Valuation April 2026
TCS — Investment Research Report | March 2026 ZUMEDHA EQUITY RESEARCH NSE: TCS | BSE: 532540 | Sector: IT Services | Report Date: March 31, 2026 CMP ₹2,390 ▼ −34% (52W) 52W High ₹3,710 52W Low ₹2,348 Mkt Cap ₹8.65L Cr Rating ACCUMULATE Investment…
CIPLA Share Price Analysis April 2026
Cipla Ltd — Investment Research Report Zumedha Equity Research · Indian Listed Securities · Pharmaceuticals & Healthcare · 03 April 2026 NSE: CIPLA · Pharma & Healthcare Cipla Limited India’s…